BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 25967456)

  • 1. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes.
    Chen Y; Mu X; Wang S; Zhao L; Wu Y; Li J; Li M
    Oncol Rep; 2013 Jan; 29(1):288-96. PubMed ID: 23129262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
    Xu D; Ma P; Gao G; Gui Y; Niu X; Jin B
    Tumour Biol; 2015 Sep; 36(10):7743-53. PubMed ID: 25936342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP.
    Miao HL; Pan ZJ; Lei CJ; Wen JY; Li MY; Liu ZK; Qiu ZD; Lin MZ; Chen NP; Chen M
    J Cell Biochem; 2013 Mar; 114(3):625-31. PubMed ID: 23060277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells.
    Sakurai M; Shibata K; Umezu T; Kajiyama H; Yamamoto E; Ino K; Nawa A; Kikkawa F
    Gynecol Oncol; 2010 Nov; 119(2):332-6. PubMed ID: 20701957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
    Li Y; Xiao M; Guo F
    Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F; Zhang X; Cao Y; Wang Y; Zhang X
    BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
    Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
    FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
    Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
    Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
    Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
    Ruan J; Liu F; Chen X; Zhao P; Su N; Xie G; Chen J; Zheng D; Luo R
    Int J Mol Med; 2011 Oct; 28(4):497-503. PubMed ID: 21617840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
    Lu Q; Xu L; Li C; Yuan Y; Huang S; Chen H
    Tumour Biol; 2016 Nov; 37(11):14605-14614. PubMed ID: 27619677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice.
    Wang X; Jiang W; Kang J; Liu Q; Nie M
    Oncol Rep; 2015 Aug; 34(2):891-9. PubMed ID: 26035556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.
    Zhang P; Zhang P; Zhou M; Jiang H; Zhang H; Shi B; Pan X; Gao H; Sun H; Li Z
    Carcinogenesis; 2013 Nov; 34(11):2639-46. PubMed ID: 23764753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
    Liu YL; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
    Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
    Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.